Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+17.3%
5Y CAGR+23.1%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+17.3%/yr
vs +27.5%/yr prior
5Y CAGR
+23.1%/yr
Recent deceleration
Acceleration
-10.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $366.28M | +40.5% |
| 2024 | $260.72M | +1.2% |
| 2023 | $257.69M | +13.7% |
| 2022 | $226.69M | -3.5% |
| 2021 | $235.00M | +81.4% |
| 2020 | $129.58M | +17.3% |
| 2019 | $110.44M | +28.8% |
| 2018 | $85.77M | +1876.3% |
| 2017 | $4.34M | - |